Nova Eye Medical Ltd

Last Updated:
4:10 pm
Wednesday, July 16, 2025
Nova Eye Medical Ltd. engages in developing suite of novel ophthalmic treatment technologies. It operates through the following segments: Faster Growing (iTrack), Emerging (2RT), and Core Ophthalmic Mark (Lasers and Ultrasounds). The iTrack segment offers catheter device that dilates the ocular structures compromised by glaucoma. The 2RT segment includes patent-protected with significant lead on competition and a per-use recurring fee business model. The Lasers and Ultrasounds segment represents testimony to the strength of the Ellex brand and was driven by growth in sales of the high-margin Ellex Tango and Ellex Tango Reflex glaucoma lasers. The company was founded by Giuseppe Canala and Victor Previn in 1985 and is headquartered in Kent Town, Australia.
Market Cap
AU$34.10M
Volume
325631
Open
0.13
AU$
High
0.13
AU$
Low
0.13
AU$
Shares On Issue
229M
52 Week Low
0.086
AU$
52 Week High
0.285
AU$
Website
www.nova-eye.com
Sector
Healthcare
Medical Specialties
Consensus
N/A
Last Report Date
N/A
Next Report Date
N/A
Next Dividend date
N/A
Short Sell
N/A
Short Sell Change (1mth)
N/A
Free ASX Market Outlook & Top Stock Picks for 2025
Instantly access our exclusive report and see which stocks our analysts are backing for growth this year.
Download Free Report

Related

Our friendly team is here to help.

If you have any questions or feedback about our service, please feel free to contact us.